Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
Active, not recruiting · NCT04494113 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy | endometrial serous adenocarcinoma | Active, not recruiting | Early phase 1 | 2026-06-11 | NCT04494113 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | United States | 238 |
| Thomas Jefferson University Hospital | Philadelphia | United States | 271 |
| UM Sylvester Comprehensive Cancer Center at Coral Gables | Coral Gables | United States | 131 |
| UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Deerfield Beach | United States | 140 |
| UM Sylvester Comprehensive Cancer Center at Plantation | Plantation | United States | 119 |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | United States | 232 |
| VCU Massey Comprehensive Cancer Center | Richmond | United States | 273 |